Log in to save to my catalogue

Sublingual misoprostol versus intramuscular oxytocin for prevention of postpartum hemorrhage in Ugan...

Sublingual misoprostol versus intramuscular oxytocin for prevention of postpartum hemorrhage in Ugan...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1685415300

Sublingual misoprostol versus intramuscular oxytocin for prevention of postpartum hemorrhage in Uganda: a double-blind randomized non-inferiority trial

About this item

Full title

Sublingual misoprostol versus intramuscular oxytocin for prevention of postpartum hemorrhage in Uganda: a double-blind randomized non-inferiority trial

Publisher

United States: Public Library of Science

Journal title

PLoS medicine, 2014-11, Vol.11 (11), p.e1001752-e1001752

Language

English

Formats

Publication information

Publisher

United States: Public Library of Science

More information

Scope and Contents

Contents

Postpartum hemorrhage (PPH) is a leading cause of maternal death in sub-Saharan Africa. Although the World Health Organization recommends use of oxytocin for prevention of PPH, misoprostol use is increasingly common owing to advantages in shelf life and potential for sublingual administration. There is a lack of data about the comparative efficacy...

Alternative Titles

Full title

Sublingual misoprostol versus intramuscular oxytocin for prevention of postpartum hemorrhage in Uganda: a double-blind randomized non-inferiority trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_plos_journals_1685415300

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1685415300

Other Identifiers

ISSN

1549-1676,1549-1277

E-ISSN

1549-1676

DOI

10.1371/journal.pmed.1001752

How to access this item